H. pylori treatment now available

Following US FDA approval (see here) Israel’s Redhill has launched its Talicia treatment for H.pylori (Helicobacter) infections in the US. RedHill’s expanded sales force will promote Talicia to approximately 25,000 gastroenterologists, primary care physicians and other healthcare providers.


This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *